TMPyP4 tosylate
CAS: 36951-72-1
Ref. TM-T13174
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Información del producto
- TMP 1363
- 4,4',4'',4'''-Porphyrin-5,10,15,20-Tetrayltetrakis(1-Methylpyridinium)
- 5,10,15,20-Tetrakis(1-methyl-4-pyridinio)porphyrin tetra(p-toluenesulfonate)
- 5,10,15,20-Tetrakis(1-methyl-4-pyridyl)-21H,23H-porphine tetra-p-tosylate
- 5,10,15,20-Tetrakis(1-methylpyridinium-4-yl)porphyrin tetra(p-toluenesulfonate)
- 5,10,15,20-Tetrakis(1-methylpyridinium-4-yl)porphyrin tetratosylate
- 5,10,15,20-Tetrakis(N-methylpyridinium-4-yl)-21H,23H-porphine tetrakis(p-toluenesulfonate)
- 5,10,15,20-Tetrakis(N-methylpyridinium-4-yl)-21H,23H-porphyrin tetrakis(p-toluenesulfonate)
- 5,10,15,20-tetrakis(1-methyl-4-pyridyl)-21H,23H-P
- Pyridinium, 4,4′,4′′,4′′′-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis[1-methyl-, 4-methylbenzenesulfonate (1:4)
- Ver más sinónimos
- Pyridinium, 4,4′,4′′,4′′′-(21H,23H-porphine-5,10,15,20-tetrayl)tetrakis[1-methyl-, salt with 4-methylbenzenesulfonic acid (1:4)
- TMPyP 4 4-methylbenzenesulfonate
- TMPyP 4 tosylate
- TMPyP [=alpha,,gamma,delta-Tetrakis(1-methylpiridinium-4-yl)porphine p-toluenesulfonate]
- TMPyP4 tetra(p-toluene sulfonate)
- Tetrakismethylpiridiniumylporphine
- Tmp 1363
- Tppt 4
- meso-Tetra(N-methyl-4-pyridinium)porphyrin tetratoluene-p-sulfonate
- meso-Tetrakis(1-methyl-4-pyridyl)porphyrin tetra(p-tosylate)
- meso-Tetrakis(1-methylpyridinium-4-yl)porphine p-toluenesulfonate
- meso-Tetrakis(N-methylpyridinium-4-yl)porphine tetratosylate
- meso-tetra-(4-N-methyl-pyridyl)*porphine tetratos
TMPyP4 tosylate (TMP 1363) is a quadruplex-specific ligand and is a telomerase inhibitor with antitumor effects in osteosarcoma cell lines.
Propiedades químicas
Consulta técnica sobre: TM-T13174 TMPyP4 tosylate
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.